![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61P 1/16 | |
A61P 11/00 | |||
A61P 13/00 | |||
A61P 13/08 | |||
A61P 15/00 | |||
A61K 39/00 | |||
A61K 47/68 | |||
C07K 16/00 | |||
C07K 16/28 | |||
C07K 16/22 | |||
G01N 33/68 | |||
A61P 1/18 |
(11) | Number of the document | 2385955 |
(13) | Kind of document | T |
(96) | European patent application number | 10729683.2 |
Date of filing the European patent application | 2010-01-12 | |
(97) | Date of publication of the European application | 2011-11-16 |
(45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2010/020820 |
Date | 2010-01-12 |
(87) | Number | WO 2010/081173 |
Date | 2010-07-15 |
(30) | Number | Date | Country code |
144105 P | 2009-01-12 | US | |
144110 P | 2009-01-12 | US | |
249416 P | 2009-10-07 | US | |
249441 P | 2009-10-07 | US |
(72) |
STAGLIANO, Nancy, E., US
WEST, James, W., US
KAMATH, Kathryn, US
BESSETTE, Paul, H., US
GLUCK, Fred, US
SAGERT, Jason, US
DAUGHERTY, Patrick, US
|
(73) |
CytomX Therapeutics, Inc.,
151 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080,
US
|
(54) | MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF |
MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF |